Want to see TRNS full AI Analyst Report?
TRNS Stock Chart & Stats
$88.19
-$2.46(-2.82%)
At close: 4:00 PM EDT
$88.19
-$2.46(-2.82%)
Day’s Range― - ―
52-Week Range$50.23 - $100.00
Previous Close$84.85
Volume74.09K
Average Volume (3M)133.01K
Market Cap
$802.09M
Enterprise Value$1.01K
Total Cash (Recent Filing)$6.71M
Total Debt (Recent Filing)$143.25M
Price to Earnings (P/E)231.0
Beta1.03
Next Earnings
Nov 02, 2026EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.37
Shares Outstanding9,359,813
10 Day Avg. Volume103,085
30 Day Avg. Volume133,009
Financial Highlights & Ratios
PEG Ratio-9.64
Price to Book (P/B)2.35
Price to Sales (P/S)2.42
P/FCF Ratio26.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$100.00Price Target Upside13.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.76
Revenue Forecast (FY)$362.13M
Bulls Say, Bears Say
Bulls Say
Mergers And AcquisitionsThe acquisition of Essco Calibration is expected to add substantial revenue and is seen as part of the company's growth strategy.
ProfitabilityTRNS shares are expected to trade at a premium due to high visibility recurring revenue and profitability.
Revenue GrowthThe recommendation is to buy TRNS shares due to anticipated revenue growth and expanding gross margins.
Bears Say
Capital RisksRisks include dilution risk from raising additional capital.
Customer DependencyRisks include customer concentration, which could affect stability.
Market CompetitionRisks include increased competition and share volatility.
Transcat News
TRNS FAQ
What was Transcat’s price range in the past 12 months?
Transcat lowest stock price was $50.23 and its highest was $100.00 in the past 12 months.
What is Transcat’s market cap?
Transcat’s market cap is $802.09M.
When is Transcat’s upcoming earnings report date?
Transcat’s upcoming earnings report date is Nov 02, 2026 which is in 58 days.
How were Transcat’s earnings last quarter?
Transcat released its earnings results on Aug 04, 2026. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.378 by -$0.238.
Is Transcat overvalued?
According to Wall Street analysts Transcat’s price is currently Undervalued.
Does Transcat pay dividends?
Transcat does not currently pay dividends.
What is Transcat’s EPS estimate?
Transcat’s EPS estimate is 0.45.
How many shares outstanding does Transcat have?
Transcat has 9,359,813 shares outstanding.
What happened to Transcat’s price movement after its last earnings report?
Transcat reported an EPS of $0.14 in its last earnings report, missing expectations of $0.378. Following the earnings report the stock price went up 2.024%.
Which hedge fund is a major shareholder of Transcat?
Currently, no hedge funds are holding shares in TRNS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Transcat Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$100.00 (13.39% Upside)
$100.00 (13.39% Upside)
Blogger Sentiment
Neutral
TRNS Sentiment 50%
Sector Average 57%
Sector Average 57%
Hedge Fund Trend
Decreased
By 154.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $574.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.3%
Last 30 Days ▼ 9.2%
Last 30 Days ▼ 9.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.08%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
25.50%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Transcat
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
TRNS Company Deck
TRNS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong, broad-based operational momentum—particularly in Services—with double-digit top-line growth, robust Service profitability expansion, improved adjusted EBITDA, and positive free cash flow trends. Management acknowledged and quantified near-term headwinds (Distribution margin pressure from prior-year comps, higher GAAP costs from acquisitions and executive transition, and some one-time OpEx), but positioned these as manageable and largely transitory while reinforcing a clear strategy (organic growth, operational excellence, and M&A) expected to drive continued margin expansion and market share gains.View all TRNS earnings summariesTRNS Stock 12 Month Forecast
Average Price Target
$100.00
▲(13.39% Upside)
Technical Analysis
DXP Enterprises
―
EVI Industries
―
Distribution Solutions Group
―
Global Industrial Company
―
Titan Machinery
―
Ownership Overview
2.08% Insiders
42.71% Mutual Funds
21.79% Other Institutional Investors
20.20% Public Companies and
Individual Investors